U.S. closer to having COVID-19 vaccines for children under six years old
in children two to four years old, although the vaccine did generate good immunity among those six months to two years old, and the company has since tested an additional, third dose of the vaccine to produce a stronger immune response. The FDA will likely compare those data from Pfizer-BioNTech against those from Moderna in these youngest children, which are now available.
As with the Pfizer-BioNTech shot, Moderna’s study also found that antibody levels were higher among the youngest children, from six months to two years old, compared to levels among two to six year olds. Researchers aren’t clear why the youngest kids generated stronger immune responses, but it may be related to their faster growing bodies, including the organs that are responsible for making antibodies and can contribute to a more active response.
Moderna’s team tested its vaccine in this group against the Omicron variant, which is now responsible for the bulk of new infections. The efficacy in protecting kids from six months to six years old from an Omicron infection ranged from 37% to 51%, depending on the children’s ages, with the youngest enjoying stronger efficacy.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19: Homes and offices raided by police in secret PPE fraud probeA secret investigation into personal protective equipment fraud has been going on for around a year, it is believed.
Read more »
Oil prices drop further as mass COVID-19 testing begins in ChinaOIL PRICES dropped even further in early Asian trade on Thursday amid concerns about increasing COVID-19 cases in China.
Read more »
Moderna asks US to authorize Covid-19 vaccine for children under age sixModerna submits data to FDA, in hopes low-dose shots to protect babies, toddlers and preschoolers will be available by summer
Read more »
COVID-19: Government acted unlawfully when it sent patients into care homes without coronavirus testing'Care home staff are amazing and they're worth far more than we're able to pay them at the moment,' says Martin Green, CEO of Care England, as he describes the difficulties COVID-19 has created within the care sector. KayBurley 📺 Sky 501 and YouTube
Read more »
Kamala Harris Tests Positive for Covid-19Vice President Kamala Harris tested positive for COVID-19 on Tuesday, the White House announced
Read more »